The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022; bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022; Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 051d22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 18-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 18-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022) and NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17Nov2022) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Bivalent Moderna COVID19 vaccine were given after the beyond use date BUD 17-Nov-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 18-Oct-2022 and was administered on 18-Nov-2022).    No concomitant medications were provided. There was individual vial and vial size was 2.5ml. The vial was initially stored in the refrigerator on 18-Oct-2022 The vial did not undergo any temperature excursions. No treatment medication was provided. This case contains information for the 3rd of 14 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-675238, US-MODERNATX, INC.-MOD-2022-675258, US-MODERNATX, INC.-MOD-2022-675260, US-MODERNATX, INC.-MOD-2022-675261, US-MODERNATX, INC.-MOD-2022-675262, US-MODERNATX, INC.-MOD-2022-675263, US-MODERNATX, INC.-MOD-2022-675264, US-MODERNATX, INC.-MOD-2022-675265, US-MODERNATX, INC.-MOD-2022-675266, US-MODERNATX, INC.-MOD-2022-675268, US-MODERNATX, INC.-MOD-2022-675269, US-MODERNATX, INC.-MOD-2022-675270, US-MODERNATX, INC.-MOD-2022-675271 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-675238:Patient 1 US-MODERNATX, INC.-MOD-2022-675258:Patient 2 US-MODERNATX, INC.-MOD-2022-675260:Patient 4 US-MODERNATX, INC.-MOD-2022-675261:Patient 5 US-MODERNATX, INC.-MOD-2022-675262:Patient 6 US-MODERNATX, INC.-MOD-2022-675263:Patient 7 US-MODERNATX, INC.-MOD-2022-675264:Patient 8 US-MODERNATX, INC.-MOD-2022-675265:Patient 9 US-MODERNATX, INC.-MOD-2022-675266:Patient 10 US-MODERNATX, INC.-MOD-2022-675268:Patient 11 US-MODERNATX, INC.-MOD-2022-675269:Patient 12 US-MODERNATX, INC.-MOD-2022-675270:Patient 13 US-MODERNATX, INC.-MOD-2022-675271:Patient 14